Literature DB >> 18164951

Pleural effusion in hospitalized patients with Coccidioidomycosis.

Maryum Merchant1, Arthur Oliver Romero, Robert D Libke, Jose Joseph.   

Abstract

INTRODUCTION: Coccidioidomycosis is a common fungal infection primarily affecting the lungs. The prevalence and the characteristics of pleural effusion in Coccidioidomycosis are not well described. Therefore, a retrospective analysis of data from patients admitted to a teaching hospital with a diagnosis of Coccidioidomycosis and pleural effusion was done.
METHODS: All patients admitted with a diagnosis of Coccidioidomycosis were identified using ICD 9 from 114 to 114.9 from computerized medical records. Epidemiological, clinical and laboratory data were transcribed from medical records of all inpatients. Pleural effusion was identified using reports of chest radiography, ultrasound and CT scan of chest.
RESULTS: Pleural effusion occurred in 22 of 146 (15%) patients hospitalized for Coccidioidomycosis. The proportion of patients with pleuritic chest pain, cough and dyspnea were significantly higher in patients with effusion than without effusion (p<0.01). There was a tendency for pleural effusions to occur more often on the left side (p=0.064). Empyema occurred in 22.7% of pleural effusions. Pleural fluid chemistry showed that all effusions were exudates with a mean (+/-S.E.M.) pleural fluid eosinophil count of 10.3+/-4.65.
CONCLUSION: Pleural effusions are common in hospitalized patients with Coccidioidomycosis. Pleural fluid eosinophilia should alert clinician to Coccidioides immitis as a possible etiological agent especially in an endemic area. Empyema occurred in a quarter of pleural effusions and resolution required thoracotomy.

Entities:  

Mesh:

Year:  2007        PMID: 18164951     DOI: 10.1016/j.rmed.2007.11.014

Source DB:  PubMed          Journal:  Respir Med        ISSN: 0954-6111            Impact factor:   3.415


  8 in total

Review 1.  Recent advances in our understanding of the environmental, epidemiological, immunological, and clinical dimensions of coccidioidomycosis.

Authors:  Chinh Nguyen; Bridget Marie Barker; Susan Hoover; David E Nix; Neil M Ampel; Jeffrey A Frelinger; Marc J Orbach; John N Galgiani
Journal:  Clin Microbiol Rev       Date:  2013-07       Impact factor: 26.132

2.  A 37-Year-Old Man With Pleuritic Chest Pain.

Authors:  Jessica Galant-Swafford; Matthew Light; Mark W Onaitis; Stephen A Rawlings; Joshua Fierer; Judd W Landsberg
Journal:  Chest       Date:  2019-07       Impact factor: 9.410

Review 3.  Pulmonary Coccidioidomycosis: A Case Report and Literature Review.

Authors:  Tadas Alčauskas; Birutė Zablockienė; Rolandas Zablockis; Linas Svetikas; Laura Bilotaitė; Ligita Jančorienė
Journal:  Medicina (Kaunas)       Date:  2022-05-12       Impact factor: 2.948

Review 4.  Cross-Sectional Study of Clinical Predictors of Coccidioidomycosis, Arizona, USA.

Authors:  Ferris A Ramadan; Katherine D Ellingson; Robert A Canales; Edward J Bedrick; John N Galgiani; Fariba M Donovan
Journal:  Emerg Infect Dis       Date:  2022-06       Impact factor: 16.126

5.  Coccidioidomycosis: adenosine deaminase levels, serologic parameters, culture results, and polymerase chain reaction testing in pleural fluid.

Authors:  George R Thompson; Shobha Sharma; Derek J Bays; Rachel Pruitt; David M Engelthaler; Jolene Bowers; Elizabeth M Driebe; Michael Davis; Robert Libke; Stuart H Cohen; Demosthenes Pappagianis
Journal:  Chest       Date:  2013-03       Impact factor: 9.410

6.  Risk Factors and Epidemiology of Coccidioidomycosis Demonstrated by a Case of Spontaneous Pulmonary Rupture of Cavitary Coccidioidomycosis.

Authors:  Amy A Yau
Journal:  Case Rep Infect Dis       Date:  2016-01-24

7.  Bicavitary eosinophilic effusion in a dog with coccidioidomycosis.

Authors:  Tara L Piech; Jared A Jaffey; Eric T Hostnik; Mary E White
Journal:  J Vet Intern Med       Date:  2020-05-24       Impact factor: 3.333

8.  Close encounters of three kinds: Case-based report of endemic mycoses in the environs of New York city.

Authors:  Ravi Manglani; Helena Tomac Pavosevic; Liying Han; Oleg Epelbaum
Journal:  Respir Med Case Rep       Date:  2020-05-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.